title: Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3.
authors.forename: M
authors.initials: M
authors.lastname: Marchand
authors.forename: P
authors.initials: P
authors.lastname: Weynants
authors.forename: E
authors.initials: E
authors.lastname: Rankin
authors.forename: F
authors.initials: F
authors.lastname: Arienti
authors.forename: F
authors.initials: F
authors.lastname: Belli
authors.forename: G
authors.initials: G
authors.lastname: Parmiani
authors.forename: N
authors.initials: N
authors.lastname: Cascinelli
authors.forename: A
authors.initials: A
authors.lastname: Bourlond
authors.forename: R
authors.initials: R
authors.lastname: Vanwijck
authors.forename: Y
authors.initials: Y
authors.lastname: Humblet
mesh_terms: D000951:Antigens, Neoplasm; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009363:Neoplasm Proteins / Q000627:therapeutic use*
chemical_list: D000951:Antigens, Neoplasm; C072013:MAGEA3 protein, human; D009363:Neoplasm Proteins